The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
I was turned on to this by another fool. When I went to look I saw a solid stock that is recession proof but what really made me look hard is their R&D projects. If they can get thier BioGlue to work for herniated discs this could be off and running. Also they have goverment funding to research BioFoam to help stop wounded soldiers in the field. Speculative on the upside and solid on the earnings side so as to not lose if the new projects don't come to fruition. Worth the risk and am buying some in my personal account.